PRESS RELEASE published on 10/30/2024 at 14:33, 25 days 11 hours ago Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc The Vanguard Group, Inc. discloses 4.06% ownership in AngloGold Ashanti plc as of 29 October 2024 Financial Position The Vanguard Group, Inc. Rule 8.3 Ownership Disclosure AngloGold Ashanti Plc
PRESS RELEASE published on 10/30/2024 at 14:31, 25 days 11 hours ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.17% stake in SEGRO plc through an opening position disclosure. Purchase of 10p ordinary shares at 8.10 GBP per unit on 29 Oct 2024 The Vanguard Group, Inc. Stake Disclosure 10p Ordinary Shares SEGRO PLC 8.10 GBP
PRESS RELEASE published on 10/30/2024 at 14:30, 25 days 11 hours ago Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc The Vanguard Group, Inc. discloses a 3.94% stake in Hargreaves Lansdown plc as of 29 Oct 2024. Purchase of 90 securities at 10.88 GBP per unit made The Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase Hargreaves Lansdown Plc
PRESS RELEASE published on 10/30/2024 at 14:28, 25 days 11 hours ago Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc The Vanguard Group, Inc. discloses 4.90% stake in Smith (DS) plc with 67,665,283 relevant securities as at 29 October 2024 The Vanguard Group Inc. Public Disclosure Financial Holdings Smith DS Plc Stock Disclosure
BRIEF published on 10/29/2024 at 14:04, 26 days 11 hours ago Vanguard Group Discloses Position in StoneX Group Securities Takeover Code Vanguard Group Stock Disclosure StoneX Group
BRIEF published on 10/29/2024 at 14:02, 26 days 11 hours ago The Vanguard Group Discloses Position in International Paper Company Form 8.3 Takeover Code Securities Disclosure Vanguard Group International Paper
BRIEF published on 10/29/2024 at 14:01, 26 days 11 hours ago Vanguard Group Discloses Position in SEGRO plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group SEGRO PLC
BRIEF published on 10/29/2024 at 14:00, 26 days 11 hours ago Vanguard Group Discloses Stake in Hargreaves Lansdown Form 8.3 Takeover Code Securities Disclosure Vanguard Group Hargreaves Lansdown
PRESS RELEASE published on 10/29/2024 at 13:59, 26 days 11 hours ago Form 8.3 - The Vanguard Group, Inc.: StoneX Group Inc. The Vanguard Group, Inc. discloses a 6.01% stake in StoneX Group Inc. according to Form 8.3 under Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure StoneX Group
BRIEF published on 10/29/2024 at 13:59, 26 days 11 hours ago The Vanguard Group Discloses Interests in Smith (DS) plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Smith (DS) Plc
Published on 11/22/2024 at 23:55, 2 days 1 hour ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 2 days 2 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 2 days 2 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 2 days 3 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/24/2024 at 19:16, 6 hours 32 minutes ago EQS-Adhoc: RENK Group AG: Termination of mandate of CEO Susanne Wiegand and appointment of Dr. Alexander Sagel as CEO
Published on 11/24/2024 at 19:07, 6 hours 41 minutes ago EQS-Adhoc: ABO Energy KGaA reduces forecast for the 2024 annual result to EUR 20 to 25 million and confirms market expectation for the 2025 financial year
Published on 11/22/2024 at 18:14, 2 days 7 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 2 days 7 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 06:58, 3 days 18 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 6 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 8 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 4 days 8 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
